Novo Nordisk A/S 0TDD.L Stock
Novo Nordisk A/S Price Chart
Novo Nordisk A/S 0TDD.L Financial and Trading Overview
| Novo Nordisk A/S stock price | 124.93 USD |
| Previous Close | 159.4 USD |
| Open | 0 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0 - 0 USD |
| 52 Week Range | 0 - 172.74 USD |
| Volume | 380 USD |
| Avg. Volume | 3.67K USD |
| Market Cap | 3.69B USD |
| Beta (5Y Monthly) | 0.319923 |
| PE Ratio (TTM) | 0.53471 |
| EPS (TTM) | 3.03 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
0TDD.L Valuation Measures
| Enterprise Value | 2.86T USD |
| Trailing P/E | 0.53471 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.019595407 |
| Price/Book (mrq) | 36.55292 |
| Enterprise Value/Revenue | 15.212 |
| Enterprise Value/EBITDA | 32.978 |
Trading Information
Novo Nordisk A/S Stock Price History
| Beta (5Y Monthly) | 0.319923 |
| 52-Week Change | 53.70% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 172.74 USD |
| 52 Week Low | 0 USD |
| 50-Day Moving Average | 164.09 USD |
| 200-Day Moving Average | 134.71 USD |
0TDD.L Share Statistics
| Avg. Volume (3 month) | 3.67K USD |
| Avg. Daily Volume (10-Days) | 4.49K USD |
| Shares Outstanding | 2.41B |
| Float | 12.9B |
| Short Ratio | N/A |
| % Held by Insiders | 0.0069% |
| % Held by Institutions | 8.60% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 32.46% |
| Operating Margin (ttm) | 43.27% |
| Gross Margin | 84.21% |
| EBITDA Margin | 46.12% |
Management Effectiveness
| Return on Assets (ttm) | 22.77% |
| Return on Equity (ttm) | 83.49% |
Income Statement
| Revenue (ttm) | 188.29B USD |
| Revenue Per Share (ttm) | 10.42 USD |
| Quarterly Revenue Growth (yoy) | 27.00% |
| Gross Profit (ttm) | 148.51B USD |
| EBITDA | 86.86B USD |
| Net Income Avi to Common (ttm) | 61.13B USD |
| Diluted EPS (ttm) | 3.034 |
| Quarterly Earnings Growth (yoy) | 39.39% |
Balance Sheet
| Total Cash (mrq) | 27.77B USD |
| Total Cash Per Share (mrq) | 1.54 USD |
| Total Debt (mrq) | 25.52B USD |
| Total Debt/Equity (mrq) | 31.95 USD |
| Current Ratio (mrq) | 0.863 |
| Book Value Per Share (mrq) | 4.43825 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 85.12B USD |
| Levered Free Cash Flow (ttm) | 57.8B USD |
Profile of Novo Nordisk A/S
| Country | United Kingdom |
| State | N/A |
| City | Bagsvaerd |
| Address | Novo Alle 1 |
| ZIP | 2880 |
| Phone | 45 44 44 88 88 |
| Website | https://www.novonordisk.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 57089 |
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, glucagon, needles, and other chronic diseases. The Rare Disease segment offers products in the areas of haemophilia, blood disorders, endocrine disorders, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Q&A For Novo Nordisk A/S Stock
What is a current 0TDD.L stock price?
Novo Nordisk A/S 0TDD.L stock price today per share is 124.93 USD.
How to purchase Novo Nordisk A/S stock?
You can buy 0TDD.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Novo Nordisk A/S?
The stock symbol or ticker of Novo Nordisk A/S is 0TDD.L.
How many shares does Novo Nordisk A/S have in circulation?
The max supply of Novo Nordisk A/S shares is 22.74M.
What is Novo Nordisk A/S Price to Earnings Ratio (PE Ratio)?
Novo Nordisk A/S PE Ratio is 0.41176665 now.
What was Novo Nordisk A/S earnings per share over the trailing 12 months (TTM)?
Novo Nordisk A/S EPS is 3.03 USD over the trailing 12 months.